CVS Health CorpCVS
▲ PositiveCapitalrelevance
Raises 2026 EPS guidance and increases cash flow outlook after strong Q2.
Impact on stocks 1
Health Care
CVS Health CorpCVS Health reported second quarter 2026 adjusted earnings per share of $2.58, exceeding expectations and prompting the company to raise its full-year adjusted EPS guidance by $0.60 to a range of $7.90 to $8.10. The company also increased its full-year cash flow from operations outlook to at least $11.5 billion, up $2 billion from prior guidance. Adjusted operating income rose 35% year over year to $5.2 billion, with all operating segments growing earnings. CVS Health also provided preliminary 2027 commentary, stating that an adjusted EPS of at least $8.44 appears reasonable, representing about 13% growth off an adjusted baseline of $7.46.
CVS Health CorpRaises 2026 EPS guidance and increases cash flow outlook after strong Q2.